Delivery Order SPE2DB22D2006-SPE2DB24FV6CR

Award Date 11/9/23
Potential Completion Date 11/13/23
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,601.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567136727 DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product, and has an ultimate completion date of February 4, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not associated with a set-aside designation,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,067.95, is a delivery order for the supply of 4566736277 - DEXTROAMP-AMPHET ER 20 MG CAP 100S, a prescription medication. The contract has a firm fixed price and an ultimate completion date of December 13, 2024. This contract award is not designated as a set-aside and appears to be open...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,198.82, is for the delivery of 4567158258 DEXTROAMP-AMPHET ER 25 MG CAP 100S. The contract is a Delivery Order under a Firm Fixed Price structure, with an ultimate completion date of February 5, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,321.11 delivery order contract is for the supply of 4562225300 DEXTROAMP-AMPHET ER 30 MG CAP 100S, a pharmaceutical product, with a completion date of September 20, 2023. The contract has a firm fixed price pricing type and was not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999...
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB24FQ0P3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,679.16, is for the delivery of 4565609508 - DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 28, 2024. This award is not designated as a...
This federal contract award, valued at $1,722.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567458315 DEXTROAMP-AMPHET ER 10 MG CAP 100S, a pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of March 5, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp...
This federal contract award, with the ID SPE2DB22D3016|SPE2DB25FANR3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $1,797.28 and is set to expire on February 20, 2025. The contract is for the provision of 4567310464 - DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,470.35, is a delivery order for the supply of 4566478383 ! DEXTROAMP-AMPHET ER 25 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of November 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,824.60, is for the delivery of 4566939636 - DEXTROAMP-AMPHET ER 30 MG CAP 100S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the period of performance runs through January 16, 2025. This contract award is not associated with a set-aside...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,421.33, is for the delivery of 4563061784 - DEXTROAMP-AMPHET ER 20 MG CAP 100S. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 12, 2023. The contract was awarded on December 11, 2023 and does not have a set-aside...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FV6CR
    Delivery Order

This federal contract award, with the ID SPE2DB22D2006|SPE2DB24FV6CR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,091.80, is for the delivery of 4562777696 ! DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product. This is a Firm Fixed Price delivery order contract, with a completion date of November 13, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, the prime contractor, is a for-profit organization registered in the System for Award Management (SAM.gov) until June 11, 2025. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/12/25, 10:30 AM